These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 24061455)
21. Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors. Zachariah RR; Schmid S; Buerki N; Radpour R; Holzgreve W; Zhong X Obstet Gynecol; 2008 Oct; 112(4):843-50. PubMed ID: 18827127 [TBL] [Abstract][Full Text] [Related]
22. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer. Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161 [TBL] [Abstract][Full Text] [Related]
23. Free circulating DNA as possible tumour marker in colorectal cancer. Boni L; Cassinotti E; Canziani M; Dionigi G; Rovera F; Dionigi R Surg Oncol; 2007 Dec; 16 Suppl 1():S29-31. PubMed ID: 18024018 [TBL] [Abstract][Full Text] [Related]
24. Integrity of cell-free plasma DNA in patients with lung cancer and nonmalignant lung disease. Schmidt B; Weickmann S; Witt C; Fleischhacker M Ann N Y Acad Sci; 2008 Aug; 1137():207-13. PubMed ID: 18837948 [TBL] [Abstract][Full Text] [Related]
25. Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients. Marzese DM; Hirose H; Hoon DS Expert Rev Mol Diagn; 2013 Nov; 13(8):827-44. PubMed ID: 24127721 [TBL] [Abstract][Full Text] [Related]
26. Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker. Ellinger J; Albers P; Müller SC; von Ruecker A; Bastian PJ BJU Int; 2009 Jul; 104(1):48-52. PubMed ID: 19154496 [TBL] [Abstract][Full Text] [Related]
27. DNA integrity assay: a plasma-based screening tool for the detection of prostate cancer. Hanley R; Rieger-Christ KM; Canes D; Emara NR; Shuber AP; Boynton KA; Libertino JA; Summerhayes IC Clin Cancer Res; 2006 Aug; 12(15):4569-74. PubMed ID: 16899603 [TBL] [Abstract][Full Text] [Related]
28. Can quantifying free-circulating DNA be a diagnostic and prognostic marker in oral epithelial dysplasia and oral squamous cell carcinoma? Shukla D; Kale AD; Hallikerimath S; Yerramalla V; Subbiah V J Oral Maxillofac Surg; 2013 Feb; 71(2):414-8. PubMed ID: 22749518 [TBL] [Abstract][Full Text] [Related]
29. Quantification of free circulating DNA as a diagnostic marker in lung cancer. Sozzi G; Conte D; Leon M; Ciricione R; Roz L; Ratcliffe C; Roz E; Cirenei N; Bellomi M; Pelosi G; Pierotti MA; Pastorino U J Clin Oncol; 2003 Nov; 21(21):3902-8. PubMed ID: 14507943 [TBL] [Abstract][Full Text] [Related]
30. Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer. Flamini E; Mercatali L; Nanni O; Calistri D; Nunziatini R; Zoli W; Rosetti P; Gardini N; Lattuneddu A; Verdecchia GM; Amadori D Clin Cancer Res; 2006 Dec; 12(23):6985-8. PubMed ID: 17145818 [TBL] [Abstract][Full Text] [Related]
31. Diagnostic role of circulating free plasma DNA detection in patients with localized prostate cancer. Altimari A; Grigioni AD; Benedettini E; Gabusi E; Schiavina R; Martinelli A; Morselli-Labate AM; Martorana G; Grigioni WF; Fiorentino M Am J Clin Pathol; 2008 May; 129(5):756-62. PubMed ID: 18426736 [TBL] [Abstract][Full Text] [Related]
32. Integrity and Quantity of Total Cell-Free DNA in the Diagnosis of Thyroid Cancer: Correlation with Cytological Classification. Salvianti F; Giuliani C; Petrone L; Mancini I; Vezzosi V; Pupilli C; Pinzani P Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28672797 [TBL] [Abstract][Full Text] [Related]
33. Increased DNA integrity in colorectal cancer. Leszinski G; Lehner J; Gezer U; Holdenrieder S In Vivo; 2014; 28(3):299-303. PubMed ID: 24815830 [TBL] [Abstract][Full Text] [Related]
34. Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies. Ellinger J; Müller DC; Müller SC; Hauser S; Heukamp LC; von Ruecker A; Bastian PJ; Walgenbach-Brunagel G Urol Oncol; 2012; 30(4):509-15. PubMed ID: 20870429 [TBL] [Abstract][Full Text] [Related]
35. CST6 promoter methylation in circulating cell-free DNA of breast cancer patients. Chimonidou M; Tzitzira A; Strati A; Sotiropoulou G; Sfikas C; Malamos N; Georgoulias V; Lianidou E Clin Biochem; 2013 Feb; 46(3):235-40. PubMed ID: 23006792 [TBL] [Abstract][Full Text] [Related]
36. Value of circulating cell-free DNA analysis as a diagnostic tool for breast cancer: a meta-analysis. Lin Z; Neiswender J; Fang B; Ma X; Zhang J; Hu X Oncotarget; 2017 Apr; 8(16):26625-26636. PubMed ID: 28460452 [TBL] [Abstract][Full Text] [Related]
37. Role of cell-free plasma DNA as a diagnostic marker for prostate cancer. Allen D; Butt A; Cahill D; Wheeler M; Popert R; Swaminathan R Ann N Y Acad Sci; 2004 Jun; 1022():76-80. PubMed ID: 15251943 [TBL] [Abstract][Full Text] [Related]
38. Multiparametric analysis of cell-free DNA in melanoma patients. Salvianti F; Pinzani P; Verderio P; Ciniselli CM; Massi D; De Giorgi V; Grazzini M; Pazzagli M; Orlando C PLoS One; 2012; 7(11):e49843. PubMed ID: 23209607 [TBL] [Abstract][Full Text] [Related]
39. Quantification of Circulating Free DNA as a Diagnostic Marker in Gall Bladder Cancer. Kumari S; Tewari S; Husain N; Agarwal A; Pandey A; Singhal A; Lohani M Pathol Oncol Res; 2017 Jan; 23(1):91-97. PubMed ID: 27475647 [TBL] [Abstract][Full Text] [Related]
40. Serum DNA hypermethylation in patients with kidney cancer: results of a prospective study. Hauser S; Zahalka T; Fechner G; Müller SC; Ellinger J Anticancer Res; 2013 Oct; 33(10):4651-6. PubMed ID: 24123044 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]